AI Article Synopsis

  • Mitochondrial reactive oxygen species (ROS) contribute to the progression of diabetic retinopathy (DR), and the study investigates whether simvastatin can reduce ROS production linked to diabetes-induced retinal damage.
  • Diabetic rats were given simvastatin for 24 weeks, and experiments were conducted on retinal cells to measure various biological markers and effects, including ROS levels and mitochondrial function.
  • Results showed that simvastatin improved mitochondrial health, lowered ROS production, and diminished harmful factors like VEGF and p38 MAPK activity, suggesting a protective role against retinal damage in diabetes through a mechanism involving PGC-1alpha.

Article Abstract

Objective: Mitochondrial reactive oxygen species (ROS) plays a key role in diabetic retinopathy (DR) pathogenesis. However, whether simvastatin decreases diabetes-induced mitochondrial ROS production remains uncertain. The aim of this study was to clarify the beneficial effects and mechanism of action of simvastatin against diabetes-induced retinal vascular damage.

Research Design And Methods: Diabetic rats and control animals were randomly assigned to receive simvastatin or vehicle for 24 weeks, and bovine retinal capillary endothelial cells (BRECs) were incubated with normal or high glucose with or without simvastatin. Vascular endothelial growth factor (VEGF) and peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) in the rat retinas or BRECs were examined by Western blotting and real-time RT-PCR, and poly (ADP-ribose) polymerase (PARP), and p38 MAPK were examined by Western blotting. Mitochondrial membrane potential (Deltapsim) and ROS production were assayed using the potentiometric dye 5,5',6,6'- Tetrachloro1,1',3,3'-tetraethyl-benzimidazolylcarbocyanine iodide (JC-1) or CM-H(2)DCFDA fluorescent probes.

Results: Simvastatin significantly upregulated PGC-1alpha (P < 0.01), subsequently decreased Deltapsim (P < 0.05) and ROS generation (P < 0.01), inhibited PARP activation (P < 0.01), and further reduced VEGF expression (P < 0.01) and p38 MAPK activity (P < 0.01). Those changes were associated with the decrease of retinal vascular permeability, retinal capillary cells apoptosis, and formation of acellular capillaries.

Conclusions: Simvastatin decreases diabetes-induced mitochondrial ROS production and exerts protective effects against early retinal vascular damage in diabetic rats in association with the inhibition of mitochondrial ROS/PARP pathway mediated by PGC-1alpha. The understanding of the mechanisms of action of statins has important implications in the prevention and treatment of mitochondrial oxidative stress-related illness such as DR.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927955PMC
http://dx.doi.org/10.2337/db10-0638DOI Listing

Publication Analysis

Top Keywords

retinal vascular
16
diabetic rats
12
ros production
12
inhibition mitochondrial
8
mitochondrial reactive
8
reactive oxygen
8
oxygen species
8
pathway mediated
8
peroxisome proliferator-activated
8
proliferator-activated receptor
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!